Pulmonary artery pressure response to percutaneous mitral valvuloplasty: Associated factors and clinical implications.
Igor Ferreira de SalesLucas Lodi-JunqueiraGuilherme Rafael Sant'Anna AthaydeMarta Eugenia AlciciTatiana Costa DiamantinoLucas Campos Barbosa E SilvaFrederico Vargas Botinha MacedoClara Leal FragaBreno Camargos Mucelli SpalaorPedro Victor Silva ValenteJuliana Rodrigues SoaresTimothy C TanWilliam Antonio de Magalhães EstevesMaria do Carmo Pereira NunesPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)
In patients with MS undergoing PMV, pulmonary pressures may not reduce immediately after the procedure, despite adequate opening of the valve. Abnormal PAP response can be predicted from baseline clinical and valvular characteristics as well as post-procedural left ventricular compliance. The lack of any immediate reduction in mPAP is not associated with long-term adverse outcomes.
Keyphrases
- pulmonary artery
- aortic stenosis
- pulmonary hypertension
- left ventricular
- aortic valve
- mitral valve
- transcatheter aortic valve replacement
- ejection fraction
- coronary artery
- transcatheter aortic valve implantation
- pulmonary arterial hypertension
- minimally invasive
- mass spectrometry
- left atrial
- atrial fibrillation
- ms ms
- hypertrophic cardiomyopathy
- acute myocardial infarction
- multiple sclerosis
- coronary artery disease
- heart failure
- radiofrequency ablation
- percutaneous coronary intervention